G00055MO
| Organisms | Evidence |
|---|---|
| Human betaherpesvirus 5 | |
| Helicobacter pylori | |
| Neisseria gonorrhoeae | |
| Shigella dysenteriae | |
| Homo sapiens (human) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| ST3GAL6 | CMP-Neu5Ac |
|
free |
|
free | |
| ST3GAL6 | CMP-Neu5Ac |
|
R |
|
R | |
| FUT2 | GDP-Fuc |
|
Free |
|
Free | |
| FUT5 | GDP-Fuc |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| ST3GAL6 | CMP-Neu5Ac |
|
free |
|
free | |
| ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
| ST3GAL6 | CMP-Neu5Ac |
|
R |
|
R | |
| FUT2 | GDP-Fuc |
|
Free |
|
Free |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
|---|---|---|---|---|
| ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
| ST6GALNAC2 | CMP-Neu5Ac |
|
octyl | |
| ST3GAL1 | CMP-Neu5Ac |
|
free | |
| CHST2 | PAPS |
|
-O-naphthalenemethanol | |
| CHST10 | PAPS |
|
R |
| Pathway Name | Organism |
|---|---|
| E.coli O136 | Escherichia coli |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl 3b:b-dgal-HEX-1:5 LIN 1:1d(2+1)2n 2:1o(4+1)3d
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 39115362 | LacdiNAc to LacNAc: remodelling of bovine α-lactalbumin N-glycosylation during the transition from colostrum to mature milk | Gazi I | 2024 Jul 26 |
|
| 38349796 | Targeting the glycan epitope type I N-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells | Rossdam C | 2024 Feb 13 |
|
| 38398516 | GlcNAc6ST2/CHST4 Is Essential for the Synthesis of R-10G-Reactive Keratan Sulfate/Sulfated N-Acetyllactosamine Oligosaccharides in Mouse Pleural Mesothelium | Takeda-Uchimura Y | 2024 Feb 07 |
|
| 39625714 | Efficient and Cost-Effective Synthesis of N-Acetyllactosamine by Sequential Modular Enzymatic Cascade Reactions Involving NTP Regeneration | Jiao R | 2024 Dec 03 |
|
| 39330281 | Novel Galectins Purified from the Sponge Chondrilla australiensis: Unique Structural Features and Cytotoxic Effects on Colorectal Cancer Cells Mediated by TF-Antigen Binding | Hayashi R | 2024 Aug 31 |
|
| 39178339 | Influence of Selective Deoxyfluorination on the Molecular Structure of Type-2 N-Acetyllactosamine | Kurfiřt M | 2024 Aug 23 |
|
| 39095616 | Efficient derivatization-free monitoring of glycosyltransferase reactions via flow injection analysis-mass spectrometry for rapid sugar analytics | Thiele U | 2024 Aug 03 |
|
| 38619967 | Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells | Zhuang X | 2024 Apr 23 |
|
| 36835132 | Selectively Modified Lactose and N-Acetyllactosamine Analogs at Three Key Positions to Afford Effective Galectin-3 Ligands | Abdullayev S | 2023 Feb 13 |
|
| 35696780 | Efficient synthesis of N-acetyllactosamine using immobilized β-galactosidase on a novel 3D polymer support | Zhao SW | 2022 Oct |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025